eHealth Initiative is forming a new drug safety program, eHI Connecting Communities for Drug Safety Collaboration.
eHealth Initiative is launching a new collaborative research project aimed at improving drug safety, the eHI Connecting Communities for Drug Safety Collaboration. The program, which brings together public health organizations as well as companies such as Pfizer, Johnson & Johnson, and Eli Lilly, will sponsor projects in Indianapolis and Boston. This initiative is intended to contribute to the creation of an active drug safety surveillance system-a key provision of the recently enacted Food and Drug Administration Amendments Act (FDAAA) of 2007. The collaboration also expects its findings to contribute to and build on those of the Reagan-Udall Foundation, a new private and independent nonprofit organization established by Congress under the FDAAA and chaired by former CMS head Mark McClellan. Results of the collaborative effort will be placed in the public domain to accelerate the timeliness and effectiveness of drug safety efforts.